Fairmount Funds Management LLC, Director, 10% Owner at Oruka Therapeutics, Inc. (ORKA), sold 3,553,410 shares at $84.43 ($300.0M) on 2026-07-01, disclosed to the SEC on 2026-07-01.
Open-market sale of $300.0M ORKA by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VRDN | BUY | 2026-05-13 | $20.0M | — | Filing → |
| ZBIO | BUY | 2026-04-01 | $3.0M | — | Filing → |
| COGT | SELL | 2026-03-31 | $242.6M | — | Filing → |